HCA

SEC source: 0001209191-18-013641 · doc4.xml · nonDerivative · entry 2

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,874

SEC source: 0001209191-18-013641 · doc4.xml · nonDerivative · entry 1

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,064

F1 · kind: On February 4, 2015, the reporting person was granted 5,900 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013640 · doc4.xml · derivative · entry 7

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,625

Underlying: Common Stock · 5,625 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 37,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,625 stock appreciation rights.

SEC source: 0001209191-18-013640 · doc4.xml · nonDerivative · entry 2

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,941.6115

SEC source: 0001209191-18-013640 · doc4.xml · nonDerivative · entry 1

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,497.6115

F1 · kind: On February 4, 2015, the reporting person was granted 9,600 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013639 · doc4.xml · derivative · entry 10

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,125

Underlying: Common Stock · 4,125 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights.

SEC source: 0001209191-18-013639 · doc4.xml · nonDerivative · entry 2

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,189

SEC source: 0001209191-18-013639 · doc4.xml · nonDerivative · entry 1

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,486

F1 · kind: On February 4, 2015, the reporting person was granted 8,000 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013638 · doc4.xml · derivative · entry 6

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,175

Underlying: Common Stock · 2,175 shares

Expires 2024-02-05

F4 · balance_after: On February 5, 2014, the reporting person was granted 14,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 2,175 stock appreciation rights.

SEC source: 0001209191-18-013638 · doc4.xml · nonDerivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,549.4951

SEC source: 0001209191-18-013638 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,689.4951

F2 · kind: On February 5, 2014, the reporting person was granted 4,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 600 restricted stock units.

SEC source: 0001209191-18-013638 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,089.4951

F1 · kind: On February 4, 2015, the reporting person was granted 7,500 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013637 · doc4.xml · derivative · entry 6

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,625

Underlying: Common Stock · 5,625 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 37,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,625 stock appreciation rights.

SEC source: 0001209191-18-013637 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,862

SEC source: 0001209191-18-013637 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,418

F1 · kind: On February 4, 2015, the reporting person was granted 9,600 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013635 · doc4.xml · derivative · entry 5

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,375

Underlying: Common Stock · 6,375 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 42,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 6,375 stock appreciation rights.

SEC source: 0001209191-18-013635 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,504

SEC source: 0001209191-18-013635 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,073

F1 · kind: On February 4, 2015, the reporting person was granted 14,700 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013636 · doc4.xml · derivative · entry 5

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,625

Underlying: Common Stock · 5,625 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 37,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,625 stock appreciation rights.

SEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,731

SEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,287

F1 · kind: On February 4, 2015, the reporting person was granted 9,600 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013634 · doc4.xml · derivative · entry 7

HAZEN SAMUEL N · CIK 0001216838 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,375

Underlying: Common Stock · 12,375 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 82,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 12,375 stock appreciation rights.

SEC source: 0001209191-18-013634 · doc4.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,505

SEC source: 0001209191-18-013634 · doc4.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,000

F1 · kind: On February 4, 2015, the reporting person was granted 23,500 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013633 · doc4.xml · derivative · entry 6

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,375

Underlying: Common Stock · 27,375 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 182,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 27,375 stock appreciation rights.

SEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 2

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,026,069

SEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 1

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,075,178

F1 · kind: On February 4, 2015, the reporting person was granted 62,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 13

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F6 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 12

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 11

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,996 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F3 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 10

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,125

Underlying: Common Stock · 3,375 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 8

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,087

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 7

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,037

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.03 to $101.161, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 6

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,794

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 5

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 4

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 3

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 9

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,996

Underlying: Common Stock · 20,504 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F3 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,544

SEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,048

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012728 · doc4.xml · derivative · entry 3

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-18-012728 · doc4.xml · nonDerivative · entry 2

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,567

SEC source: 0001209191-18-012728 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,745

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012568 · doc4.xml · nonDerivative · entry 2

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2016 GRAT

Disclosed balance after: 0

F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: The Reporting Person's spouse is the trustee of (i) Patricia Champion Frist 2016 Grantor Retained Annuity Trust and (ii) Patricia Champion Frist May 2017 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-012568 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,855

F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $100.80 to $101.3399, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001209191-18-012573 · doc4.xml · nonDerivative · entry 2

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2016 GRAT

Disclosed balance after: 0

F3 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F4 · ownership.nature: The Reporting Person is trustee of (i) Patricia Champion Frist 2016 Grantor Retained Annuity Trust and (ii) Patricia Champion Frist May 2017 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-012573 · doc4.xml · nonDerivative · entry 1

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 389,855

F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $100.80 to $101.3399, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Healthcare, Inc. through an indirect pecuniary interest in such shares held by her spouse, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-028169 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 22,168.0001

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person directly owns 22,168.0001 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules.

SEC source: 0001209191-18-028170 · doc4.xml · nonDerivative · entry 1

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by The William R. Frist February 2018 GRAT

Disclosed balance after: 416,420.6596

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person received a gift of 22,168 units of Hercules on February 20, 2018 which were subsequently transferred to The William R. Frist February 2018 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-19-010249 · doc5.xml · nonDerivative · entry 3

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 3,531,181.4752

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F3 · ownership.nature: On February 20, 2018 The Patricia Frist Elcan 2016 Annuity Trust I transferred an aggregate of 29,575 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2016 Annuity Trust I and the Reporting Person's spouse is the trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F4 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is trustee of nine grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 51,131 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 3,495,991.4752 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.